COLOMBO, Gaia
 Distribuzione geografica
Continente #
NA - Nord America 7.437
EU - Europa 2.249
AS - Asia 1.391
SA - Sud America 33
AF - Africa 15
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.136
Nazione #
US - Stati Uniti d'America 7.392
CN - Cina 689
UA - Ucraina 527
IT - Italia 525
TR - Turchia 299
DE - Germania 276
SG - Singapore 252
PL - Polonia 203
GB - Regno Unito 199
SE - Svezia 159
FI - Finlandia 123
FR - Francia 117
ID - Indonesia 38
IN - India 38
CA - Canada 31
GR - Grecia 28
ES - Italia 17
BR - Brasile 16
MX - Messico 14
BE - Belgio 13
HK - Hong Kong 11
IR - Iran 10
CH - Svizzera 9
MY - Malesia 9
NL - Olanda 9
AU - Australia 8
PE - Perù 8
PT - Portogallo 8
VN - Vietnam 8
AT - Austria 7
CZ - Repubblica Ceca 7
IL - Israele 7
KR - Corea 7
RO - Romania 7
EG - Egitto 6
CO - Colombia 5
JP - Giappone 5
PK - Pakistan 5
TN - Tunisia 5
IE - Irlanda 4
RU - Federazione Russa 4
CL - Cile 3
JO - Giordania 3
TW - Taiwan 3
EU - Europa 2
HR - Croazia 2
HU - Ungheria 2
TH - Thailandia 2
YE - Yemen 2
ZA - Sudafrica 2
AR - Argentina 1
BG - Bulgaria 1
CY - Cipro 1
DK - Danimarca 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
SZ - Regno dello Swaziland 1
Totale 11.136
Città #
Fairfield 998
Woodbridge 955
Houston 689
Jacksonville 620
Chandler 545
Ann Arbor 469
Ashburn 433
Wilmington 370
Seattle 361
Cambridge 328
Izmir 243
Warsaw 198
Singapore 184
Nanjing 175
Princeton 153
Beijing 110
Boardman 100
Ferrara 81
San Diego 75
Shenyang 67
Nanchang 53
Hebei 44
Tianjin 37
Milan 36
Shanghai 35
Mountain View 34
Jakarta 33
Redwood City 33
Santa Clara 31
Falls Church 28
Jiaxing 27
Bremen 26
Addison 25
London 22
Los Angeles 21
New York 20
Changsha 18
Jinan 16
Parma 16
Zhengzhou 16
Norwalk 15
Orange 14
Brussels 13
Rome 13
Auburn Hills 12
Chicago 11
Kunming 11
Ningbo 11
Philadelphia 11
Verona 11
Athens 10
Des Moines 10
Hangzhou 9
Dearborn 8
Dong Ket 8
Hong Kong 8
San Mateo 8
Bologna 7
Helsinki 7
Indiana 7
Lima 7
Redmond 7
Tappahannock 7
Yellow Springs 7
Napoli 6
Paris 6
Vienna 6
Caivano 5
Changchun 5
Guangzhou 5
Hyderabad 5
Mumbai 5
Munich 5
Padova 5
Washington 5
Castegnato 4
Crescentino 4
Fuzhou 4
L'Hospitalet de Llobregat 4
Mohali 4
Rovere Veronese 4
Vancouver 4
Brno 3
Cairo 3
Columbus 3
Dallas 3
Düsseldorf 3
Fort Lauderdale 3
Guadalajara 3
Kolkata 3
Lanzhou 3
Lappeenranta 3
Piacenza 3
San Francisco 3
Santiago 3
Tel Aviv 3
Turin 3
Vicenza 3
Walnut 3
Wenzhou 3
Totale 8.097
Nome #
Studio di uno spray topico di sucralfato gel e cidofovir per la terapia antivirale di ovini 263
In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates 242
Effect of residual water content on the physico-chemical properties of sucralfate dried gel obtained by microwave drying 199
Opportunity and challenges of nasal powders: Drug formulation and delivery 172
Chimerical agglomerates of lecithin/chitosan nanoparticles for powder nasal delivery 169
Biological In Vitro Models for Absorption by Nonoral Routes 159
The development of a single-use, capsule-free multi-breath tobramycin dry powder inhaler for the treatment of cystic fibrosis 151
PRINCIPI DI CALCOLO FARMACEUTICO 149
null 147
Respiratory Drug Delivery 144
Combinations of colistin solutions and nebulisers for lung infection management in cystic fibrosis patients 142
Nasal powders of thalidomide for local treatment of nose bleeding in persons affected by hereditary hemorrhagic telangiectasia 137
Spray-dried amikacin sulphate powder for inhalation in cystic fibrosis patients: The role of ethanol in particle formation 133
Assemblage of Novel Release Modules for the Development of Adaptable Drug Delivery Systems 122
null 122
Ex vivo permeation of tamoxifen and its 4-OH metabolite through rat intestine from lecithin/chitosan nanoparticles 117
Skin permeation of 5-methoxypsoralen from topical dosage forms 116
Dry powder inhalers: An overview of the in vitro dissolution methodologies and their correlation with the biopharmaceutical aspects of the drug products 113
The Effect of Residual Water on Antacid Properties of Sucralfate Gel Dried by Microwaves 111
Module assemblage technology for floating systems: in vitro flotation and in vivo gastro-retention 109
Floating modular drug delivery systems with buoyancy independent of release mechanisms to sustain amoxicillin and clarithromycin intra-gastric concentrations 109
The suitability of disintegrating force kinetics for studying the effect of manufacturing parameters on spironolactone tablet properties 108
null 106
From tablets to pharmaceutical nanotechnologies: Innovation in drug delivery strategies for the administration of antimalarial drugs 106
Bioadhesive film for transdermal delivery of lidocaine: in vitro and in vivo behavior 104
Soft Agglomerates of Pantoprazole Gastro-resistant Microparticles for Oral Administration and Intestinal Release 102
Novel Platforms for Oral Drug Delivery 102
null 101
Prolongation of sciatic nerve blockade by in situ cross-linked hyaluronic acid 100
In vitro and in vivo study of 5-methoxypsoralen skin concentration after topical application 100
null 100
Esomeprazole immediate release tablets: Gastric mucosa ex vivo permeation, absorption and antisecretory activity in conscious rats 100
Swellable and Rigid Matrices: Controlled Release Matrices with Cellulose Ethers 99
Mechanisms of formation and disintegration of alginate beads obtained by prilling 99
Dry powder inhalers of gentamicin and leucine: formulation parameters, aerosol performance and in vitro toxicity on CuFi1 cells 98
Therapeutic paint of cidofovir/sucralfate gel combination topically administered by spraying for treatment of orf virus infections 97
null 97
Artesunate-clindamycin multi-kinetics and site-specific oral delivery system for antimalaric combination products 96
null 96
Post-iontophoresis transport of ibuprofen lysine across rabbit ear skin 95
Surface-modified nanocarriers for nose-to-brain delivery: From bioadhesion to targeting 95
Design of experiments (DoE) in pharmaceutical development 93
Prolonged duration local anesthesia with lipid-protein-sugar particles containing bupivacaine and dexamethasone 92
null 91
Prolonged duration local anesthesia from tetrodotoxin-enhanced local anesthetic microspheres 90
Methacholine dry powder inhaler as a new tool for bronchial challenge test 89
Effect of excipient composition on the biocompatibility of bupivacaine-containing microparticles at the sciatic nerve 89
Bioadhesive sucralfate gel-based suspension containing cidofovir for spray treatment of viral infections in lamb and sheep 88
null 88
Prolonged duration local anesthesia with lipid-protein-sugar particles containing bupivacaine and dexamethasone 87
null 86
Formulation Strategies for Antitubercular Drugs by Inhalation 86
null 85
null 85
null 83
Nasal administration and brain targeting of an antiischemic agent 82
Geometric Release Systems: Principles, Release Mechanisms, Kinetics, Polymer Science, and Release-Modifying Material 82
null 82
null 82
The use of fatty acids as absorption enhancer for pulmonary drug delivery 82
null 81
null 81
null 80
Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction 80
null 79
null 79
Brain Targeting of an Antiischemic Agent by Nasal Administration of Microparticles 77
Alginate and cell combination product for wound healing 74
N6-cyclopentyladenosine : selective brain targeting by nasal administration of microparticles 73
The role of dissolution test in a comparison of generic and branded controlled-release products 73
null 73
The formulation of a novel macrolide solution pressurised metered dose inhaler: the use of Clarithromycin as an anti-inflammatory for bronchiectasis therapy 72
Bioencapsulation methods for cell inclusion in polysaccharidic matrices for clinical applications 71
Chitosan coated human serum albumin nanoparticles: A promising strategy for nose-to-brain drug delivery 71
Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer’s disease 71
A new 5-methoxypsoralen formulation for the topical treatment of psoriasis 69
Single layer dermal patch: skin accumulation assessed by tape stripping 69
Efficacy and biocompatibility of bupivacaine-loaded lipid-protein-sugar particles for prolonged duration local anesthesia 68
A Study for the Development of Mesalazine Multiparticulate Dosage Forms for Colon Delivery in Pediatric Patients 68
Chitosan-coated nanoparticles: Effect of chitosan molecular weight on nasal transmucosal delivery 67
Combination of alginate and cells for skin regeneration 65
Film for active ingredients dermal and transdermal administration 65
Autoassembled nanoparticles of lecithin/chitosan for oral delivery of the anticancer drug tamoxifen citrate 65
Multi-kinetics and site-specific release of gabapentin and flurbiprofen from oral fixed-dose combination: in vitro release and in vivo food effect 65
A Clinical Study of a Methacholine Dry Powder for the Bronchial Challenge Test 63
null 63
null 62
In vitro and in vivo study of a desmopressin nasal powder 61
Diclofenamic acid-vitamin C conjugates: stability and interaction studies with ascorbate transporters 60
Strategies in bupivacaine delivery for prolonged duration local anesthesia 59
Cell culture studies of polysaccharide films loaded with cisplatin for the loco-regional therapy of malignant pleural mesothelioma 59
Therapeutic paint for simultaneous delivery of sucralfate gel and cidofovir in the treatment of veterinary viral skin infections 59
Nose-to-brain delivery of ribavirin (RBV) for the treatment of viral encephalitis 59
In vitro transport studies across excised nasal mucosa for three drug candidates to nose-to-brain delivery 59
Nasal powders of morphine microcrystals agglomerates 59
Progesterone-loaded lecithin/chitosan isopropylmyristate nanoparticles for transmucosal delivery 58
Enhancing ribavirin nose-to-brain delivery by powder formulation for veterinary CNS infections 58
Study of a Sucralfate gel-based therapeutic paint for antiviral drug topical application by spraying 58
Construction of amikacin dry powders for inhalation by a Central Composite Design 58
Produzione e caratterizzazione di nanoparticelle ottenute dall'interazione ionica tra lecitina e chitosano 57
Totale 9.457
Categoria #
all - tutte 46.824
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.372
Totale 49.196


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.834 0 0 0 339 182 289 198 238 183 253 107 45
2020/20211.894 140 194 117 191 67 151 182 210 74 280 188 100
2021/20221.265 51 154 98 66 55 76 44 76 41 101 118 385
2022/20231.299 164 54 27 159 238 193 34 127 167 15 86 35
2023/2024608 93 91 34 23 41 25 15 28 9 28 55 166
2024/2025395 93 46 229 27 0 0 0 0 0 0 0 0
Totale 11.350